FDA 483 - BASF AS avd Sandefjord - January 24, 2025

An FDA inspection of BASF AS avd Sandefjord, an API manufacturer, revealed two significant observations. The firm failed to conduct thorough deviation investigations, specifically regarding root cause identification and verification of corrective actions. Additionally, scheduled equipment preventative maintenance events were not performed as scheduled, and no justifications were provided for these delays.